Genotwin Overview
- Founded
-
2020
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Early Stage VC
- Investors
-
1
Genotwin General Information
Description
Developer of a genomics platform designed to transform the diagnosis, surveillance, and treatment of pathogens. The company's platform realizes the epidemiologic analysis of infectious diseases and precision anti-cancer medicine by using genome big data analysis technology, enabling clinicians to address and control the emergence of novel pathogens at an early stage.
Contact Information
Website
www.genotwin.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
- 38 Clarence Avenue
- Bridgewater, MA 02324
- United States
+1 (347) 000-0000
Genotwin Timeline
Genotwin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Dec-2021 | 00000 | Completed | Startup | ||
| 1. Angel (individual) | 15-Dec-2020 | 00000 | 00000 | Completed | Startup |
Genotwin Executive Team (7)
Genotwin Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Seunghee Ham | Genotwin | Co-Founder & Board Member | 000 0000 |
Genotwin Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Genotwin Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Mint Venture Partners (Seoul) | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |